Pfizer CEO: Third COVID vaccine dose likely needed within 12 months
Apr 16 2021
"But all of that needs to be confirmed and again the variants will play a key role", he continued and added: "It is extremely important to suppress the pool of people that can be susceptible to the virus because they are vaccinated with high-efficacy vaccines".
An official from the Omani Ministry of Health spoke exclusively to Times of Oman, "A person receiving two doses of Pfizer vaccine may need a third dose 12 months after the date of the second dose, according to the studies and researches as stated by Pfizer".
New Zealand has secured 10 million doses of Pfizer's Covid vaccine - enough for every New Zealander to be vaccinated twice, the Government has said.
The CEO of Pfizer believes people will need a third dose of the Covid-19 vaccine six to 12 months after their first round.
Speaking in an interview on American television, Pfizer CEO, Albert Bourla, said that his company was now evaluating long-term vaccination needs, but that a third dose and annual revaccination were a "likely scenario".
"Together we are demonstrating that through mass vaccinations we can defeat the COVID-19 pandemic and save lives", Bourla said in a video address.
The Pfizer coronavirus vaccine that has been made in partnership with German company BioNTech is touted to be 91 per cent effective in preventing the virus.
On Thursday, a White House official also said that the United States is preparing for the possibility of a booster shot that would be needed between nine and 12 months.
"In poorer countries, including in Africa, we sell it at cost".
In comments published on Thursday, Dr Bourla said that the Pfizer-BioNTech vaccine has proved to provide immunity for six months.
And Bourla said Thursday the company was working on a new formula that would allow the vaccine to be stored for four to six months at a normal temperature, rather than the minus 70 degrees Celsius (minus 94 Fahrenheit) or below now required.
President Joe Biden's chief science officer David Kessler told a congressional committee meeting on Thursday that his team are "expecting" to have to administer booster jabs.
"We don't know everything at this moment", he told the House Select Subcommittee on the Coronavirus Crisis.
'It seems strong but there is some waning of that and no doubt the variants challenge.they make these vaccines work harder. By the middle of April, around 120 million people in the US had received at least one dose, according to figures from the US Centers for Disease Control and Prevention.